The Senate Appropriations Committee holds a hearing to examine proposed budget estimates for fiscal year 2026 for the Food and Drug Administration (FDA) at 10:30 a.m. ET on May 22.
Witnesses include Dr. Martin Makary, commissioner of the Food and Drug Administration.